Approaches to the design of effective HIV-1 protease inhibitors.
about
Genetic selection for dissociative inhibitors of designated protein-protein interactions.Universal peptidomimetics.Minimalist and universal peptidomimetics.Dimeric switch of Hakai-truncated monomers during substrate recognition: insights from solution studies and NMR structureDesign, synthesis and evaluation of a potent substrate analog inhibitor identified by scanning Ala/Phe mutagenesis, mimicking substrate co-evolution, against multidrug-resistant HIV-1 protease.Discovery of nonpeptide, peptidomimetic peptidase inhibitors that target alternate enzyme active site conformations.Novel strategies for targeting the dimerization interface of HIV protease with cross-linked interfacial peptides.P1 and P1' para-fluoro phenyl groups show enhanced binding and favorable predicted pharmacological properties: structure-based virtual screening of extended lopinavir analogs against multi-drug resistant HIV-1 protease.Antiviral propierties of 5,5'-dithiobis-2-nitrobenzoic acid and bacitracin against T-tropic human immunodeficiency virus type 1.Synthesis and anti-HIV-1 integrase activity of cyano pyrimidinones.Developing HIV-1 Protease Inhibitors through Stereospecific Reactions in Protein Crystals.Effect of Biomolecular Conformation on Docking Simulation: A Case Study on a Potent HIV-1 Protease Inhibitor.Interaction of ganoderic acid on HIV related target: molecular docking studiesDrug-resistant HIV-1 protease regains functional dynamics through cleavage site coevolution.Fusion/entry inhibitors as therapies for HIV.
P2860
Q31801167-7BF69F92-CA68-422F-B172-FC3D0E53EED2Q33779385-B05BD791-E7B8-4F0E-BDA3-E598FBE12C75Q33869896-08D7C243-D4F9-49CE-A2BA-A8C06906D455Q34170693-E80FDD69-CCA8-479D-BB41-7CA333F30F58Q34885997-9FA11EE6-A895-4988-BA19-8F30F7FE2249Q34906937-B91D27D8-E082-4835-8133-2299C7F8B49DQ34906959-8AB7104B-3691-4991-8214-F94D0F8709DFQ35057007-009F64E8-7A7E-45FA-ADFC-A770F6D38D5AQ39160523-ED812B71-4302-449D-8332-06758AE60CC0Q39777355-D359590F-2E75-4C88-A8C3-E30250750EC3Q40467926-AC4FA1E7-64F5-41E2-AC07-404FA9477F65Q41020492-76D710A2-5D4D-4556-9ABD-8827D8753EB8Q41158674-D3A7501A-88DA-4C8B-A93B-68C440037D39Q43136211-ED329084-CD8D-499E-B4FB-49A082B6C515Q53853233-955D8D02-E32F-49AA-9899-4BAAB5A4CF7C
P2860
Approaches to the design of effective HIV-1 protease inhibitors.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Approaches to the design of effective HIV-1 protease inhibitors.
@ast
Approaches to the design of effective HIV-1 protease inhibitors.
@en
type
label
Approaches to the design of effective HIV-1 protease inhibitors.
@ast
Approaches to the design of effective HIV-1 protease inhibitors.
@en
prefLabel
Approaches to the design of effective HIV-1 protease inhibitors.
@ast
Approaches to the design of effective HIV-1 protease inhibitors.
@en
P356
P1476
Approaches to the design of effective HIV-1 protease inhibitors.
@en
P2093
P304
P356
10.2174/0929867003375146
P577
2000-04-01T00:00:00Z